CNY 16.14
(0.25%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 495.28 Million | 400.43 Million | 552.34 Million | 383.74 Million | 447.35 Million | 481.01 Million |
Cost of Revenue | 324.85 Million | 260.71 Million | 339.44 Million | 219.67 Million | 211.21 Million | 251.33 Million |
Gross Profit | 170.43 Million | 139.72 Million | 212.9 Million | 164.07 Million | 236.14 Million | 229.67 Million |
Operating Expenses | 137.69 Million | 62.9 Million | 52.49 Million | 44.66 Million | 71.99 Million | 53.06 Million |
Selling, General and Administrative Expenses | 37.17 Million | 15.21 Million | 8.9 Million | -24.77 Million | -108.37 Million | -78.39 Million |
Research and Development Expenses | 25.9 Million | 19.79 Million | 17.99 Million | 12.52 Million | 16.2 Million | 15.74 Million |
Other Expenses | 74.61 Million | 11.05 Million | -340.78 Thousand | 3.98 Million | 2.87 Million | 5.52 Million |
Cost and Expenses | 462.55 Million | 323.62 Million | 391.94 Million | 264.33 Million | 283.2 Million | 304.4 Million |
Operating Income | 32.73 Million | 110.07 Million | 167.52 Million | 125.59 Million | 167.13 Million | 171.02 Million |
Interest Expense | 2.04 Million | 1.85 Million | 1.25 Million | 68.96 Thousand | 341.71 Thousand | 2.71 Million |
Income Tax Expense | 9.06 Million | 20.71 Million | 24.81 Million | 19.3 Million | 27.56 Million | 27.25 Million |
Earnings before Tax | 30.11 Million | 121.13 Million | 167.18 Million | 129.24 Million | 166.67 Million | 173.25 Million |
Net Income | 21.05 Million | 100.4 Million | 142.37 Million | 109.93 Million | 139.1 Million | 145.99 Million |
Earnings Per Share Basic | 0.10 | 0.47 | 0.66 | 0.51 | 0.65 | 0.92 |
Earnings Per Share Diluted | 0.10 | 0.47 | 0.66 | 0.51 | 0.65 | 0.92 |
Weighted Average Shares Outstanding | 214.62 Million | 214.63 Million | 214.63 Million | 214.63 Million | 214.63 Million | 157.97 Million |
Weighted Average Shares Outstanding (Diluted) | 214.62 Million | 214.63 Million | 214.63 Million | 214.63 Million | 214.63 Million | 157.97 Million |
Gross Margin | 0.34 | 0.35 | 0.39 | 0.43 | 0.53 | 0.48 |
EBIT Margin | 0.10 | 0.34 | 0.33 | 0.35 | 0.46 | 0.44 |
Profit Margin | 0.04 | 0.25 | 0.26 | 0.29 | 0.31 | 0.30 |
EBITDA | 47.27 Million | 138.56 Million | 183.38 Million | 133.21 Million | 179.85 Million | 182.54 Million |
Earnings Before Tax Margin | 0.07 | 0.27 | 0.30 | 0.33 | 0.37 | 0.36 |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Revenue | 124.28 Million | 143.18 Million | 104.03 Million | 131.79 Million | 495.28 Million | 127.11 Million |
Cost of Revenue | 96.4 Million | 94.68 Million | 75.04 Million | 90.48 Million | 317.71 Million | 78.59 Million |
Gross Profit | 27.88 Million | 48.49 Million | 28.98 Million | 41.31 Million | 177.57 Million | 48.51 Million |
Operating Expenses | 19.1 Million | 13.46 Million | 12.53 Million | 15.76 Million | 62.8 Million | 14.17 Million |
Selling, General and Administrative Expenses | 9.33 Million | 7.91 Million | 8.36 Million | -12.21 Million | - | 17.4 Million |
Research and Development Expenses | 9.77 Million | 5.54 Million | 3.99 Million | 5.11 Million | - | 7.17 Million |
Other Expenses | - | -267.2 Thousand | -1.47 Million | -623.08 Thousand | -2.61 Million | -811.6 Thousand |
Cost and Expenses | 115.51 Million | 108.15 Million | 87.58 Million | 106.25 Million | 380.51 Million | 92.76 Million |
Operating Income | 8.77 Million | 35.03 Million | 23.75 Million | 20.94 Million | 32.73 Million | -73.58 Million |
Interest Expense | 343.16 Thousand | 693.42 Thousand | 785.46 Thousand | 503.84 Thousand | 1.92 Million | 490.47 Thousand |
Income Tax Expense | 2.39 Million | 6.39 Million | 3.69 Million | 7.15 Million | 9.06 Million | -10.21 Million |
Earnings before Tax | 15.53 Million | 41.96 Million | 22.27 Million | 20.32 Million | 30.11 Million | -74.4 Million |
Net Income | 13.13 Million | 35.56 Million | 18.58 Million | 13.17 Million | 21.05 Million | -64.18 Million |
Earnings Per Share Basic | 0.06 | 0.17 | 0.09 | 0.06 | - | -0.30 |
Earnings Per Share Diluted | 0.06 | 0.17 | 0.09 | 0.06 | - | -0.30 |
Weighted Average Shares Outstanding | 208.65 Million | 208.65 Million | 214.56 Million | 214.39 Million | 214.62 Million | 214.63 Million |
Weighted Average Shares Outstanding (Diluted) | 208.65 Million | 208.65 Million | 214.56 Million | 214.39 Million | 214.62 Million | 214.63 Million |
Gross Margin | 0.22 | 0.34 | 0.28 | 0.31 | 0.36 | 0.38 |
EBIT Margin | 0.13 | 0.27 | 0.22 | 0.28 | - | 0.33 |
Profit Margin | 0.11 | 0.25 | 0.18 | 0.10 | 0.04 | -0.50 |
EBITDA | 15.88 Million | 38.59 Million | 22.84 Million | 37.42 Million | - | 42.08 Million |
Earnings Before Tax Margin | 0.07 | 0.24 | 0.23 | 0.16 | 0.07 | -0.58 |
SGRO
300684
SJ
KOHINOOR
KLINIQ
300031